Skip to main content
Fig. 17 | Biomaterials Research

Fig. 17

From: Recent trends in therapeutic application of engineered blood purification materials for kidney disease

Fig. 17

a Scheme for preparation of TMNP and HMNP. b TEM images of HMNP. c Activated partial thromboplastin time (APTT) and thrombin time tests (TT) for MNP, TOPA modified MNP (TMNP) and HMNP at a concentration of 150 μg/100 μL blood. For the control group (PPP), 5 μL PBS was added instead. d APTT and TT for HMNP at concentrations of 25, 50, 100 and 150 μg/100 μL blood. Reproduced with permission [123]. Copyright 2020, American Chemical Society

Back to article page

Biomaterials Research

ISSN: 2055-7124

Contact us